...
首页> 外文期刊>Journal of substance abuse treatment >Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges
【24h】

Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges

机译:在澳大利亚Covid-19期间的仓库Buprenorphine:机会和挑战

获取原文
获取原文并翻译 | 示例
           

摘要

The COVID-19 pandemic has presented challenges for traditional models of opioid use disorder treatment worldwide. Depot buprenorphine became available in Australia shortly before the height of the COVID-19 pandemic. This timing provided us an opportunity to examine the utilization and uptake of depot buprenorphine, and to understand the particular benefits and implementation challenges associated with this new formulation of opioid agonist treatment.
机译:2019冠状病毒疾病的流行给传统的阿片类药物滥用治疗模式带来了挑战。在C2019冠状病毒疾病流行高峰之前不久,澳大利亚丁丙诺啡就可获得。这个时机为我们提供了一个机会,来检查储备丁丙诺啡的利用和摄取情况,并了解与阿片类激动剂治疗新配方相关的特殊益处和实施挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号